FindTrial
Sign In

Multi center clinical study of accurate treatment of COPD based on image phenotype

Multi center clinical study of accurate treatment of COPD based on image phenotype

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035272
Enrollment
Unknown
Registered
2020-08-06
Start date
2020-08-31
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

CLE group:phase I: LABA
phase II: LAMA
PLE group:phase I: LAMA
phase II: LABA

Sponsors

Renji Hospital, Shanghai Jiaotong Uninversity, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: COPD patients in group B according to GOLD guidelines.

Exclusion criteria

Exclusion criteria: Subpleural bullae, acute left heart failure, connective tissue disease, renal failure, hypothyroidism, liver failure, cancer, acute mental illness, benign prostatic hyperplasia and hypertrophy, glaucoma.

Design outcomes

Primary

MeasureTime frame
6-minute walking distance;—

Secondary

MeasureTime frame
CAT;Pulmonary function;Improvement of emphysema;—

Countries

China

Contacts

Public Contactwu xueling

Renji Hospital, Shanghai Jiaotong Uninversity, School of Medicine

wuxueling76@126.com+86 18321035326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026